Abdullah Taşkın
Nutrition and Dietetics Department, Faculty of Health Science, Harran University, Şanlıurfa, Turkey
[ 1 ] - Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
Objective(s): The primary cytotoxic effects of anticancer drugs like idarubicin, a chemotherapeutic agent, are not limited to neoplastic cells; they also produce similar effects in normal cells. In this study, we hypothesized that the combination of idarubicin-bromelain could make cancer cells more susceptible to cytotoxicity and genotoxicity.Material...
نویسندگان همکار